<DOC>
	<DOCNO>NCT01426113</DOCNO>
	<brief_summary>The purpose study assess safety efficacy new formulation bimatoprost ophthalmic solution compare timolol ophthalmic solution treatment paediatric patient glaucoma .</brief_summary>
	<brief_title>A Study Safety Efficacy Bimatoprost Ophthalmic Solution Paediatric Patients With Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis congenital , juvenile glaucoma Requires treatment IOPlowering medication one eye Surgical intervention indicate plan low IOP Abnormally low body weight ( 5th percentile ) Any active eye infection disease Anticipated use contact lenses study Topical ocular steroid use within 2 month History ocular trauma either eye Required chronic use ocular medication ( study medication ) study ( intermittent use artificial tear permit )</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>